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Abstract
Background: Research in the field of psychoneuroimmunology (PNI) has revealed that depression
is associated with inflammation manifested by increased levels of proinflammatory cytokines.
Discussion: The old paradigm described inflammation as simply one of many risk factors for
depression. The new paradigm is based on more recent research that has indicated that physical
and psychological stressors increase inflammation. These recent studies constitute an important
shift in the depression paradigm: inflammation is not simply a risk factor; it is the risk factor that
underlies all the others. Moreover, inflammation explains why psychosocial, behavioral and physical
risk factors increase the risk of depression. This is true for depression in general and for
postpartum depression in particular. Puerperal women are especially vulnerable to these effects
because their levels of proinflammatory cytokines significantly increase during the last trimester of
pregnancy – a time when they are also at high risk for depression. Moreover, common experiences
of new motherhood, such as sleep disturbance, postpartum pain, and past or current psychological
trauma, act as stressors that cause proinflammatory cytokine levels to rise. Breastfeeding has a
protective effect on maternal mental health because it attenuates stress and modulates the
inflammatory response. However, breastfeeding difficulties, such as nipple pain, can increase the
risk of depression and must be addressed promptly.
Conclusion: PNI research suggests two goals for the prevention and treatment of postpartum
depression: reducing maternal stress and reducing inflammation. Breastfeeding and exercise reduce
maternal stress and are protective of maternal mood. In addition, most current treatments for
depression are anti-inflammatory. These include long-chain omega-3 fatty acids, cognitive therapy,
St. John's wort, and conventional antidepressants.
Review
Depression in new mothers is common in many cultures,
affecting anywhere from 10% to 20% of postpartum
women. In some high-risk populations, the percentage
can even be as high as 40% or 50% [1]. Since depression
has devastating effects on both mother and baby, it's vital
that it be identified and treated promptly. Depressed
mothers are also more likely to stop breastfeeding with
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negative health effects for each [1]. In this paper, I
describe a psychoneuroimmunology (PNI) framework for
depression in new mothers and discuss its implications
for breastfeeding women.
Inflammation and depression
In recent years, researchers in the field of PNI have found
that inflammation is involved in the pathogenesis of
depression. Maes and colleagues first documented that
mothers with the postpartum blues had higher levels of
inflammation than mothers who did not [2]. They con-
cluded that the postpartum blues were caused by an acti-
vated inflammatory response system (IRS). In a later
paper, Maes and colleagues noted that "it is generally
accepted that in the early puerperium, there is an
increased inflammatory responsivity in the serum ... sug-
gesting an activation of the inflammatory response sys-
tem" [3] (p. 71).
When researchers first identified inflammation as increas-
ing the risk of depression, most considered it an inde-
pendent risk factor along with several others. The other
risk factors included psychosocial stress, a broad category
that included significant life changes, lack of social sup-
port, marital difficulties, infant illness or prematurity, and
low income. Psychological trauma, another risk factor,
includes current trauma or a history of trauma, which cre-
ates a vulnerability to future stressors even when there are
no current symptoms. Sleep disturbance and pain are
physical stressors that are common among new mothers
and increase the risk of depression. The model portrayed
on Figure 1 shows these as individual risk factors and rep-
resents the old paradigm.
More recent research, however, suggests a new paradigm
for understanding depression. PNI researchers have found
that physical and psychosocial stressors (i.e., all the risk
factors for depression) increase inflammation [4-6]. These
recent studies constitute an important shift in the depres-
sion paradigm: inflammation is not simply a risk factor; it
is the  risk factor that underlies all the others [7]. This
model is portrayed on Figure 2.
Puerperal women are especially vulnerable because their
inflammation levels rise significantly during the last tri-
mester of pregnancy – a time when they are also at high
risk for depression. Moreover, common experiences of
new motherhood, such as sleep disturbance, postpartum
pain, psychological stress, and trauma also increase
inflammation. Physical and psychosocial risk factors for
depression are still important to identify. The old para-
digm identifies the known causes of depression in new
mothers.
The new paradigm moves the field forward and provides
an answer to the next question: why? Why would psycho-
social risk factors, such as lack of social support or marital
strife or stress, increase the risk of depression? Why would
depression be more likely in women who are sleep
deprived or who have experienced trauma or pain? The
new paradigm provides perspective on the mechanism by
which previously identified risk factors increase risk. It
also guides practitioners in their intervention efforts and
suggests that targeting inflammation may increase
women's resilience to other stressors.
Breastfeeding and depression in mothers
Breastfeeding also has an important role to play in moth-
ers' postpartum mental health. Groër and Davis noted
that "breastfeeding confers some psychoneuroimmuno-
logical benefits to mothers" (p. 599) in part because of its
impact on stress [8]. In an earlier review, Groër, Davis and
Hemphill noted that although women experience many
stressors in the postpartum period, breastfeeding protects
them by inducing calm, lessening maternal reactivity to
stressors, and increasing nurturing behaviour [9]. The PNI
approach is relevant to lactation specialists because it
demonstrates that breastfeeding can protect mothers'
mental health and is worth preserving whenever possible.
Method of literature review
The studies cited below were assembled from a wide vari-
ety of sources. Literature searches on PubMed and
PsychInfo were conducted on depression, postpartum/
postnatal depression, depression and inflammation,
proinflammatory cytokines, pain, sleep disturbances,
HPA dysfunction and depression, trauma, omega-3 fatty
acids, inflammation and depression. In addition, several
key PNI and psychiatry journals were manually searched
for relevant articles including Psychoneuroendocrinology,
Psychosomatic Medicine, Psychosomatic Research, Biological
Psychiatry, Health Psychology, American Journal of Psychiatry,
British Journal of Psychiatry, and British Medical Journal.
Where appropriate, literature from the field of cardiovas-
cular medicine was cited as this literature contains many
studies that examine the links between depression,
inflammation and risk of cardiovascular disease.
Physical and psychological stressors that increase 
inflammation and risk of depression
To understand the role of inflammation in depression, it's
helpful to first review the normal physiologic response to
stress. When faced with a threat, human bodies have a
number of interdependent mechanisms in place designed
to preserve our lives. The sympathetic nervous system
responds by releasing catecholamines (norepinephrine,
epinephrine, and dopamine). The hypothalamic-pitui-
tary-adrenal (HPA) axis also responds: the hypothalamus
releases corticotrophin releasing hormone (CRH), theInternational Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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pituitary releases adrenocorticotropin hormone (ACTH),
and the adrenal cortex releases cortisol, a glucocorticoid.
The immune system responds by increasing production of
proinflammatory cytokines, which increase inflamma-
tion. Cytokines are proteins that regulate immune
response. Proinflammatory cytokines help the body heal
wounds and fight infection by stimulating an inflamma-
tory response [10].
Maes and colleagues described the interrelatedness of
these systems and noted that inflammation influences lev-
els of serotonin and catecholamines, and has an impact
on the HPA axis, which controls cortisol levels [7,11].
Once inflammation starts, it triggers the HPA axis to
release cortisol, and the release of more proinflammatory
substances [12]. Breastfeeding appears to attenuate these
effects by lowering cortisol, ACTH, epinephrine and nore-
pinephrine [8].
(1) Immune and HPA dysfunction in depression
Depression is also related to some distinct abnormalities
in the immune system and HPA axis. I will describe the
immune effects first. For many years, researchers consid-
ered depression to be primarily immunosuppressive in
that they observed that depressed people had fewer lym-
phocytes and the natural killer cells (NK) had lower cyto-
toxicity [6,13]. These are both indications of a suppressed
immune system. More recent studies, however, indicate
that depression causes an immune dysfunction, meaning
that some aspects are suppressed, while other aspects are
Risk Factors for Depression in New Mothers – Old Paradigm Figure 1
Risk Factors for Depression in New Mothers – Old Paradigm. depicts six risk identified risk factors for depression in 
new mothers: stress, sleep disturbance, pain, inflammation, psychological trauma, and a history of abuse depression or trauma.International Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
Page 4 of 14
(page number not for citation purposes)
elevated [13,14]. In depressed people, inflammation is
increased, including high levels of proinflammatory
cytokines and acute-phase proteins, such as C-reactive
protein (CRP), which are a physiologic response to
chronic distress [6,12,13]. Levels of inflammation can be
40% to 50% higher in depressed people than their non-
depressed counterparts [15].
The proinflammatory cytokines that researchers identified
most consistently as being elevated in depression are
interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necro-
sis factor-α (TNF-α), and more recently, interferon-γ (IFN-
γ) [15]. In the last trimester of pregnancy, levels of proin-
flammatory cytokines rise [2]. When these cytokines are
within normal levels, they are adaptive because they help
prevent infection. When they are abnormally high, they
increase the risk of depression. Proinflammatory
cytokines cause a constellation of sickness behaviors in
humans, which includes alterations in sleep, appetite,
activity, mood, energy, sexual activity and socialization –
all behaviors associated with depression [2]. The relation-
ship between inflammation and depression appears to be
bidirectional: inflammation increases the risk of depres-
sion and depression increases inflammation.
Depression can also influence the systems that normally
keep inflammation in check, such as the HPA axis. Corti-
sol is anti-inflammatory and is generally secreted when
Risk Factors for Depression in New Mothers – New Paradigm Figure 2
Risk Factors for Depression in New Mothers – New Paradigm. depicts five risk factors for depression in new mothers 
(stress, sleep disturbance, pain, psychological trauma and a history of abuse or trauma) with inflammation as the underlying risk 
factor.International Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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inflammation levels get too high. However, depressed
people either have abnormally low levels of cortisol or
they become less sensitive to cortisol. In either case, corti-
sol fails to restrain the inflammatory response. In one
recent study of 72 women, depressed women had higher
levels of IL-6 and TNF-α in response to an acute stressor
than women who weren't depressed [15]. Also they were
less sensitive to glucocorticoids that normally terminate
the inflammatory response system [15]. The authors con-
cluded that the depressed women had a blunted cortisol
response to stress [15]. Groër and Morgan in their study of
200 postpartum women also noted a down-regulation of
the HPA axis and abnormally low levels of cortisol in
depressed women at 4 to 6 weeks postpartum [10].
(2) Depression, inflammation and preterm birth
Depression poses another health risk to puerperal women
– increased risk of preterm birth. Several researchers have
noted that depression and posttraumatic stress disorder
increase risk of preterm birth, and inflammation may
explain why [16,17]. In a study of 200 women at 4 to 6
weeks postpartum, depressed mothers had significantly
smaller babies, more life stress, and more negative life
events [10]. These women also had abnormally low corti-
sol levels meaning that the inflammatory response was
not restrained. Another study in Goa, India (n = 270)
found that babies of mothers who were depressed during
their third trimester of pregnancy were significantly more
likely to have low birth weight babies than their non-
depressed counterparts. Mothers who were most severely
depressed were at highest risk (Odds Ratio, OR: 2.5); these
findings were significant even after for controlling for
maternal age, maternal and paternal education, and pater-
nal income [18].
In a prospective cohort study of 681 women, the rate of
spontaneous preterm birth for depressed women was
more than twice that of women who were not depressed
(9.7% vs. 4%; OR: 3.3) [16]. The authors speculated on
two possible pathways by which depression might lead to
preterm birth. Depression can lead to elevated cortisol lev-
els, which increases corticotrophin releasing hormone
(CRH). CRH triggers parturition. The other possible
mechanism they cited is activation of the proinflamma-
tory cytokines and prostaglandin E2, which is secreted in
response to cortisol and proinflammatory cytokines. Pros-
taglandin E2 plays a major role in uterine contractions
[16].
The proinflammatory cytokines IL-6, IL-8, and TNF-α
ripen the cervix before birth and these are also elevated
when women are under stress. In a study of 30 pregnant
women, Coussons-Read and colleagues found that TNF-α
and IL-6 levels were significantly higher, and the anti-
inflammatory cytokine IL-10 was significantly lower, in
mothers who were stressed compared with mothers who
weren't [4]. The authors hypothesized that inflammation
was the likely mechanism to explain the relationship
between maternal stress and preterm birth. They noted
that high levels of inflammation (particularly IL-6 and
TNF-α) were associated with preeclampsia and premature
labor. Infection also increases the risk of preterm birth
and TNF-α is released in response to both viral and bacte-
rial infections. They concluded that high levels of proin-
flammatory cytokines may in fact endanger human
pregnancies [4].
Inflammation may also explain another set of findings
regarding preterm birth. In a study of 291 low-income
pregnant women, participants were randomly assigned to
receive either DHA-enriched eggs or regular eggs that they
were to consume daily during the last trimester of their
pregnancy [19]. This sample was predominantly African
American (73%), a group generally at risk for preterm
birth. DHA is a long-chain omega-3 fatty acid with anti-
inflammatory effects (these effects are described in more
detail in a subsequent section). Women who received the
DHA-enriched eggs had an average increase in gestation of
six days (SD = 2.3) [19]. The DHA-enriched eggs may have
increased gestation length by decreasing inflammation.
(3) Physical and psychological stressors
As described in the previous section, human bodies are
designed to respond a certain way when they are threat-
ened. These threats can be physical or psychological; the
physiological response is the same. Moreover, some types
of stressors have both physical and psychological ele-
ments. Three stressors – sleep disturbance, pain, and
trauma – are particularly relevant to new mothers. Studies
that examine these stressors with regard to inflammation
are described below.
(a) Sleep disturbances and fatigue
Sleep disturbances and fatigue are physical and psycho-
logical stressors that increase the risk of depression.
Fatigue and sleep problems are often overlooked or mini-
mized because they are so common in new mothers. But
fatigue is often of great concern to mothers, and quantity
and quality of sleep can alter stress both immune function
and emotional well-being [9]. McEwen noted that short
periods of disrupted sleep can wreck havoc on the physi-
cal health of even non-depressed people [20]. Disrupted
sleep elevates evening cortisol levels (suggesting dysregu-
lation of the HPA axis), increases glucose and insulin lev-
els, and increases insulin resistance. And disturbed sleep is
nearly universal in the postpartum period. In addition,
mothers of premature babies or babies with high-needs
temperaments may wake frequently at night well beyond
the postpartum period. Psychological trauma and current
stress can also compromise sleep quality [21,22]. All ofInternational Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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these factors increase the risk of depression both directly
and indirectly through sleep disturbance.
Sleep disturbance and depression are also mutually main-
taining conditions: sleep disturbance can cause depres-
sion and depression causes sleep disturbances. Ross et al.
noted that several factors suggest a relationship between
sleep problems and depression in postpartum women
[23]. These are as follows.
1) Insomnia is a significant risk for new-onset depression;
2) Sleep disturbances are common in most psychiatric dis-
orders;
3) Treatments that manipulate sleep and circadian
rhythms can be used to treat mood disorders.
In a review of polysomnographic studies of postpartum
women, Ross et al. noted that there are differences in REM
latency for women at risk for postpartum depression or
who have current postpartum depression – reduced REM
latency, increased total sleep time during pregnancy and
decreased total sleep time postpartum [23]. REM latency
refers to the time during the night when REM sleep
becomes the predominant pattern. A pattern of reduced
REM latency means that REM occurs earlier in the nightly
sleep cycle, and is a symptom of depression. As a result of
these sleep disturbances, women are more fatigued during
the day. The authors noted that these changes may repre-
sent an underlying vulnerability to depression as they do
with non-postpartum populations. They also noted that
women with a history of affective disorders may be more
sensitive to the normal physiologic changes of pregnancy.
Sleep disturbances and fatigue too are related to cytokine
levels. When proinflammatory cytokine levels are high,
fatigue increases. Moreover, the body experiences dis-
turbed sleep as a physiological stressor [24]. In a sleep
study of 22 patients with major depressive disorder
(MDD) and 18 age-matched controls, inflammation was
associated with sleep disturbances [25]. Prolonged sleep
latency and REM density (two markers of disturbed sleep)
were better predictors of IL-6 and ICAM (intercellular
adhesion molecules – another inflammatory marker)
than depressive symptoms. The authors concluded that
sleep disturbances were at least the partial cause of ele-
vated inflammation in depressed people [25].
Another study examined the role of the proinflammatory
cytokine IL-1β in postpartum women [26]. The research-
ers found that higher levels of IL-1β were related to fatigue
in women at four weeks postpartum. The authors specu-
lated that IL-1β may have an indirect link to postpartum
depression through fatigue [26]. Sleep deprivation is also
a stressor that both activates the hypothalamic-pituitary-
adrenal (HPA) axis and increases cytokine release in
response [27].
In a study of women four to six weeks postpartum, Groër
and colleagues found that mothers' fatigue levels corre-
lated with their levels of stress and depression [27]. They
also found that fatigue, stress and depression increased
the risk of infection for both mother and baby. Fatigue,
stress and depression make the immune system less effec-
tive, which increases the risk of infection. Interestingly,
the same study also found that mothers who were
stressed, depressed and fatigued had lower levels of prol-
actin in both their serum and milk. These same mothers
also had higher levels of melatonin in their milk, the hor-
mone that regulates circadian rhythms [27].
In a more recent study of 200 women at 4 to 6 weeks post-
partum, Groër and Morgan found that depressed mothers
reported more fatigue and daytime sleepiness than non-
depressed mothers [10]. The depressed mothers had
abnormally low levels of cortisol, which may also cause
their fatigue. The authors describe how chronic fatigue
syndrome, various chronic pain syndromes, and posttrau-
matic stress disorder are also associated with low cortisol
levels. The depressed mothers also had more health prob-
lems since the baby was born and had more health-related
events such as sprains, dental pain, and allergies. They had
higher levels of perceived stress, anxiety and more nega-
tive life events. The serum IL-6 levels were three times
higher in the depressed mothers, but this was not a signif-
icant difference because of measurement variability [10].
In summary, sleep disturbances and fatigue are physical
stressors that increase the risk of depression. The relation-
ship between sleep problems and proinflammatory
cytokines appears to be bidirectional: sleep disturbances
increase cytokines and cytokines increase sleep distur-
bance by delaying sleep onset, increasing daytime fatigue,
and perpetuating the cycle of disturbed sleep and inflam-
mation. Motivala and colleagues hypothesized that inter-
ventions that target disordered sleep may also lower
inflammation, thereby lowering the risk of depression
[25].
(b) Pain
Pain is another physical and psychological stressor related
to increased inflammation and the risk of depression.
Pain and depression are highly co-morbid conditions and
may have a common etiology [28]. There are many types
of pain that postpartum women are likely to experience.
Pain can be the result of birth difficulties or breastfeeding
difficulties. Pain can be caused by prior psychological
trauma, which lowers the pain threshold so that normal
sensations are perceived as painful [28]. Pain can also beInternational Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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caused by autoimmune disease that may appear for the
first time in the postpartum period [1].
The relationship between pain and inflammation also
appears to be bidirectional. When a woman experiences
pain, stress hormones and levels of proinflammatory
cytokines increase. High levels of proinflammatory
cytokines, in turn, increase pain. Cytokines (especially IL-
1) are stimulated by Substance P. Substance P is the neu-
ropeptide that is high in patients with pain. In one study,
patients with major depression or posttraumatic stress dis-
order were compared to healthy controls (n = 101) [30].
The patients with depression or PTSD had significantly
elevated levels of Substance P in their cerebrospinal fluid.
Moreover, the levels of Substance P rose significantly
when the patients were presented with a laboratory-
induced stressor that reminded them of their traumatic
event. The authors concluded that Substance P was related
to both depression and PTSD and responded to acute
stress [30]. High levels of Substance P are also related to
lower levels of serotonin, which increases the risk of
depression. In addition, cytokines increase prostaglandin
synthesis, including the prostaglandin cyclooxygenase-2
(COX-2), which increases pain [24,31-33]. In a study of
mothers at eight weeks postpartum, a history of either vio-
lence or depression increased the risk of postpartum
health problems including several types of postpartum
pain [29].
Sleep disturbances can also increase pain. An example of
the relationship between disrupted sleep and pain is in
the chronic pain syndrome fibromyalgia. While this is a
controversial diagnosis in some circles, researchers have
noted that patients with fibromyalgia have a number of
physiologic abnormalities that cannot be influenced by
patient report. These include increases in Substance P (up
to three times as much compared to healthy controls),
decreases in serotonin and the serotonin metabolite 5-
HIAA in the cerebral spinal fluid, abnormal brain activa-
tion patterns, and of relevance to the present discussion,
abnormal sleep patterns [28]. A pattern frequently found
in patients with fibromyalgia is interrupted delta (slow-
wave) sleep. Interrupted delta sleep means that patients'
bodies do not make repairs to muscular micro-traumas
that have occurred during the day. The net result is all-over
body pain [34]. Fibromyalgia has even been induced in
the laboratory, where patients' sleep was monitored, and
every time they went into delta sleep they were woken up.
By the next morning, they had head-to-toe pain, which
resolved once they had a normal night's sleep [34].
An interesting exception to the pain-sleep disturbance
phenomenon is co-sleeping. Polysomnographic studies of
breastfeeding mothers who are sleeping next to their
babies for all or part of the night indicate that the mothers
spend less time in deep sleep than mothers who are not
co-sleeping. Despite significantly decreased slow-wave
sleep, co-sleeping mothers do not appear to report an
increase in body pain [35]. Co-sleeping may be less stress-
ful for mothers than needing to completely wake for night
time feeding. Or the higher levels of prolactin that co-
sleeping mothers have may have an impact decrease
inflammation and pain. This issue has never been specifi-
cally addressed and would be an interesting topic for
future research.
Pain can be a potent trigger for depression in postpartum
women. A common type of pain in the first few weeks
after birth is nipple pain. A study of 113 breastfeeding
women (48 with nipple pain, 65 without) demonstrated
that women with pain were significantly more likely to be
depressed than women without pain (38% vs. 14%) [36].
Women in the pain group also had significantly higher
scores on the Profile of Mood States questionnaire. Once
the pain resolved, the scores on these scales dropped to
normal levels [36].
Unfortunately, nipple pain appears to be common, even
among educated, middle-class women – the group most
likely to breastfeed. In one study in Minneapolis, Minne-
sota, an astonishing 50% of women had nipple pain at
five weeks [37]. Another study from Toronto, Canada had
similar results; 52% of mothers reported cracked or sore
nipples at two months postpartum [29].
In summary, postpartum pain is a common experience
among women who have recently given birth [29].
Addressing pain promptly, and providing mothers the
means to cope with their pain can halt the cascade of
stress hormones and proinflammatory cytokines, decreas-
ing their risk of depression.
(c) Current trauma or history of trauma
Psychological trauma can also have an impact on depres-
sion and cytokine levels. Like depression, posttraumatic
stress disorder (PTSD) is a dysregulation of a normal stress
response. Cortisol levels can be abnormally high or low.
Previous studies found that people with PTSD had abnor-
mally low cortisol levels. When cortisol is not there to
inhibit the inflammatory response system, people who
have PTSD have increased cytokine activity [38-40]. Even
if cortisol is elevated, the receptors can be less sensitive to
cortisol and fail to restrain the inflammatory response
[41,42].
According to the Diagnostic and Statistical Manual [43], a
traumatic event is one in which the person felt that death
or serious injury was possible for themselves or a loved
one, and the person responded with fear, helplessness or
horror. In addition, there must be symptoms in each ofInternational Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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these three clusters: 1) intrusion: frequent re-experiencing
of the event via nightmares or intrusive thoughts, 2)
avoidance: numbing or lack of responsiveness to or avoid-
ance of current events that remind patients of their
trauma, and 3) hyperarousal: persistent symptoms of
increased arousal including jumpiness, sleep disturbances
or poor concentration [43].
PTSD can be caused by a pre-existing trauma, such as sex-
ual assault or natural disaster. Or it can be caused by the
birth itself. In a review of the literature, Beck found that
the rates of women who met full criteria for PTSD follow-
ing birth ranged from 1.5% to 6% [44]. The study with
1.5% excluded women with prior depression or PTSD –
the very women who are most vulnerable. Even the high-
est percentage (6%) may seem relatively small. By way of
comparison, in the weeks following the September 11th
terrorist attacks in 2001, 7.5% of residents of lower Man-
hattan living near Ground Zero met full criteria for PTSD
[45]. It's shocking to realize that the percentage of women
meeting full criteria for PTSD after birth is not substan-
tially different than the rates following a terrorist attack.
Moreover, even if women do not meet full criteria, they
often have symptoms and these can be troublesome,
interfere with their sleep and increase the risk of depres-
sion [1,46].
1) The impact of highly stressful births on breastfeeding
Women may also have experiences that are highly stress-
ful, while not leading to PTSD [28], can cause breastfeed-
ing difficulties. Women who experience highly stressful
births are likely to have abnormally high cortisol levels in
the first few days postpartum. And elevated cortisol levels
may cause problems. In a study from Guatemala,
researchers measured the cortisol levels of 136 women
before or after birth. For women with the highest levels of
cortisol, lactogenesis II (the onset of copious milk supply)
was delayed for several days [47].
2) Prior history of depression or trauma
A woman with a history of depression or trauma is often
more vulnerable to current life stresses. One way that that
vulnerability manifests is a more rapid inflammatory
response to current stressors. This effect has been noted in
both human and animal research. For example, in an ani-
mal study, prior exposure to a stressor (in this case, ines-
capable foot shock) led to a hypersensitivity of the
inflammatory response system and more rapid release of
proinflammatory cytokines when exposed to a subse-
quent stressor [48]. This is consistent with human studies
of childhood abuse that indicate that men and women
who are abused in childhood have a significantly
increased vulnerability when exposed to current life stres-
sors. They may respond to these current situations with
either depression of PTSD [39].
Kiecolt-Glaser and colleagues also noted that stress and
depression appear to prime the inflammatory response so
that it is more reactive to subsequent stressors [5]. During
the postpartum period, women experience a number of
significant stressors, such a sleep deprivation and postpar-
tum pain, that increase inflammation and the subsequent
risk of depression [2,5]. Women with prior histories of
severe stress, depression and trauma are at increased risk
of postpartum depression in part because of the way their
bodies are primed to react to stress.
Implications: goals of prevention and treatment
A PNI approach suggests two important and related goals
for the prevention and treatment of depression in new
mothers: reduce maternal stress and reduce maternal
inflammation. These recommendations are described
below.
(1) Reduce maternal stress
Since physical and psychological stressors trigger the
inflammatory response system, the first goal for prevent-
ing or treating depression is to reduce maternal stress. And
one important way to do this is for health care providers
to encourage mothers to breastfeed, and to support ongo-
ing breastfeeding relationships.
(a) The adaptiveness of breastfeeding
When breastfeeding is going well, it protects mothers
from stress [8,9], thereby protecting maternal mood. A
study of 28 mothers who were both breast- and bottle-
feeding measured mothers' stress levels immediately
before and after both types of feeding. This study was a
major methodological improvement over previous stud-
ies in that women served as their own controls. Since there
were not pre-existing differences between the groups, it
was possible to attribute the observed difference in mood
to feeding method alone. The researchers found that
breastfeeding decreased negative mood and bottle feeding
decreased in positive mood in the same women [49].
Another study compared stress levels of three groups of
women: women who were exclusively breastfeeding (n =
84), women who were exclusively feeding infant formula
(n = 99), and non-postpartum healthy volunteers (n = 33)
[50]. The researcher found that breastfeeding women had
lower perceived stress, depression and anger, and more
positive life events than the controls. Serum prolactin was
inversely related to stress and mood in formula-feeding
mothers, but this was not true for the breastfeeding moth-
ers. The author concluded that breastfeeding appears to be
mildly protective of maternal mood [50]. More recently,
these same researchers found in a study of 200 women at
4–6 weeks postpartum, that depressed women were sig-
nificantly less likely to be breastfeeding and they had sig-International Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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nificantly lower serum prolactin levels. They also reported
significantly more life stress and anxiety [10].
A study of 43 breastfeeding women found that both
breastfeeding and holding their babies without breast-
feeding significantly decreased ACTH, plasma cortisol,
and salivary free cortisol [51]. In response to an induced
stressor, cortisol responses were attenuated in breastfeed-
ing women for a short time after feeding their babies. The
authors concluded that suckling, but not breastfeeding in
general, provided a short-term suppression of the stress-
related cortisol response and HPA axis response to mental
stress [51]. They argued that this short-term suppression
provided several evolutionary and biological advantages.
It isolated the mother from distracting stimuli, facilitated
the women's immune system, protected the babies from
high cortisol in the milk and prevented stress-related inhi-
bition of lactation. Based on their review, Groër, Davis
and Hemphill drew similar conclusions [9]. They noted
that the neuroendocrinology of breastfeeding women
possibly down-regulated the stress response. This down-
regulation protects the breastfeeding mother and directed
her toward milk production, conservation of energy, and
nurturing behaviors.
Exclusive breastfeeding also increases the effectiveness of
the mothers' immune system [50,51]. In a study of 181
women at 4 – 6 weeks postpartum, perceived stress,
depression, anxiety, anger and negative life events were
related to decreased immune competence for the formula-
feeding mothers [52]. This relationship was not present in
the breastfeeding mothers who were protected from the
harmful effects of stress on immunity [52].
Breastfeeding and stress in babies
Breastfeeding not only reduces stress for mothers; it also
lowers stress that babies experience when their mothers
are depressed. Jones et al. compared the infants of four
groups of women: depressed mothers who were either
breast or bottle feeding, and non-depressed mothers who
were either breast or bottle feeding [53]. The outcome was
the babies' electroencephalogram (EEG) patterns. This
measure is used to determine if infants have physiological
symptoms of depression – in this case, a pattern of right
frontal asymmetry. Right frontal asymmetry is a pattern
that also is found in chronically depressed adults.
The researchers found that the babies of the depressed/
non-breastfeeding mothers had the abnormal pattern of
right-frontal asymmetry [53]. In contrast, infants of the
depressed/breastfeeding mothers had normal EEG pat-
terns. In other words, breastfeeding protected these babies
from the effects of maternal depression. The authors
explained their findings by noting that the depressed/
breastfeeding mothers did not disengage from their
babies the way the depressed/bottle-feeding mothers did.
The depressed/breastfeeding mothers continued to look
at, touch and stroke their babies because these behaviors
are built into the breastfeeding relationship. In contrast,
when a mother bottle feeds, she doesn't have to even hold
her baby. So it is easier for her to disengage, leading to the
symptoms that babies typically exhibit when their moth-
ers are depressed [53].
In summary, breastfeeding protects maternal mood by
lowering stress. When stress levels are lower, the mother's
inflammatory response system will not be activated,
thereby lowering her risk of depression. However positive
these results, I must issue one caveat: they only apply
when breastfeeding is going well. As noted earlier, when
breastfeeding that is not going well, particularly if there is
pain, it becomes a trigger to depression rather than some-
thing that lessens the risk. Mothers' mental health is yet
another reason to intervene quickly when breastfeeding
difficulties arise.
(b) Exercise and depression
Another way mothers can reduce stress is to exercise,
which has also been found to alleviate depression. In a
Finnish population study (n = 3,403), men and women
who exercised two to three times a week experienced sig-
nificantly less depression, anger, cynical distrust, and
stress than men and women who exercised less frequently
[54].
The efficacy of exercise was also demonstrated in a rand-
omized trial of patients with major depressive disorder. In
this study, 156 patients with major depression (>50 years
old) were randomized into one of three treatment groups:
aerobic exercise alone, sertraline (antidepressant) alone,
and a combination of exercise and sertraline [55]. After
four months, all three groups showed improvement and
there were no significant difference between the groups.
In other words, those who were in the exercise-only group
experienced as much recovery as those who took either
medication alone or in combination with exercise. The
more striking findings, however, occurred at 10 months.
At that time, the exercise-only group had a significantly
lower rate of relapse than either the medication alone or
medication/exercise groups. The authors speculated that
this was because by learning to exercise, the study had
given the exercise-only group a coping tool that they could
use when faced with life stressors [55]. This study is partic-
ularly noteworthy because it was the first to try exercise as
a treatment for major depression.
In summary, by linking stress and depression, the PNI
framework provides a rationale for why exercise would be
an effective intervention for depression – something prac-
titioners can share with mothers. The goal is improvedInternational Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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mental health, not weight loss (although some might
occur). Depressed mothers need this information because
exercise is often the very last thing they feel like doing. But
exercise is an effective technique for both decreasing their
risk of depression and helping them cope with the stresses
and strains of early motherhood.
(2) Reduce inflammation
The second recommendation is for mothers to reduce
inflammation. As described earlier, psychosocial and
physical risk factors for depression increase inflamma-
tion, which increases depression risk. One way to decrease
inflammation is through consumption of long-chain
omega-3 fatty acids. Omega-3s show promise in the treat-
ment of mood disorders according to a 2006 expert panel
convened by the American Psychiatric Association [56].
And they do so, in part, by decreasing inflammation.
These studies and their relevance to pregnant and postpar-
tum women are described below.
(a) Long-chain omega-3 fatty acids and depression
Over the past 100 years, the diet of people in many West-
ern cultures has changed substantially. Some have theo-
rized that these changes could explain the increase in
depression during this same time period [2,5,57]. Of par-
ticular concern is the change in the ratio of omega-
6:omega-3 fatty acids, with dramatically decreased
omega-3s and increased omega-6s. Omega-6 fatty acids
are found in vegetable oils and are a staple of processed
foods. Omega-3s are found in fatty fish and some plant
sources. While some omega-6s are necessary for good
nutrition, they become harmful when the ratio of omega-
6s to omega-3s is too high – as it is in modern diets.
Kiecolt-Glaser and colleagues noted that the hunter-gath-
erer diet had an estimated ratio of omega-6s:omega-3s of
2:1 or 3:1 [5]. The typical North American diet ranges
from 15:1 to 17:1. In Australia and New Zealand the ratio
is 10:1 [57]. With regard to depression, the long-chain
omega-3s are of interest: EPA and DHA [58]. ALA is the
omega-3 found in flax and other plant sources. ALA is an
essential fatty acid, and while important for good nutri-
tion, it has no efficacy in the prevention or treatment of
depression [58].
(i) Anti-inflammatory activity of omega-3s
Omega-3s are powerful anti-inflammatories and lower
proinflammatory cytokines. In a large population study,
high levels of omega-3s (ALA, EPA and DHA) were related
to lower levels of the proinflammatory cytokines IL-1α,
IL-1β, IL-6, and TNF-α and higher levels of anti-inflamma-
tory cytokines such as IL-10. For people with low levels of
omega-3s, the opposite was true: these people had high
levels of proinflammatory cytokines and low levels of
anti-inflammatory cytokines [59]. Higher levels of proin-
flammatory cytokines increase the risk for depression.
In a study of older adults, the combination of depression
and higher omega-6: omega-3 ratios dramatically
increased levels of proinflammatory cytokines (IL-6 &
TNF-α) beyond the individual contribution of either vari-
able alone. The authors noted that a diet with a high ratio
of omega-6s:omega-3s increases the risk of both depres-
sion and diseases related to chronic inflammation includ-
ing heart disease, diabetes and cancer [5].
EPA and DHA may also increase resilience to stress by reg-
ulating and attenuating the stress response. Maes and col-
leagues noted that an imbalance of omega-6s:omega-3s
leads to an overproduction of proinflammatory cytokines
in response to psychological stress [11]. When omega-3
levels are higher, the levels of proinflammatory cytokines
are reduced. Their study included 27 college students who
were exposed to a laboratory-induced stressor. The stu-
dents with lower serum levels of omega-3s had a signifi-
cantly greater stress-induced elevation of TNF-α and IFN-
γ than those with higher serum omega-3s or a lower ratio
of omega-6s:omega-3s [11].
(ii) Omega-3s in population studies
Population studies have provided support for the efficacy
of omega-3s in preventing depression and other mental
health problems by demonstrating that populations who
naturally consume more omega-3s in their diets (usually
by eating fatty coldwater fish, e.g. such as salmon or mack-
erel) have lower rates of a variety of mental health prob-
lems. For example, populations with higher levels of EPA
and DHA in their diets had lower levels of major depres-
sion, bipolar disorder, and future suicide risk [60-62]. A
prospective study in Osaka, Japan of 865 pregnant
women, however, failed to find a relationship between
fish intake or the intake of omega-3 fatty acids and pre-
vention of postpartum depression [63]. These findings
could be due to a ceiling effect in that the entire popula-
tion already eats large amounts of seafood [63].
(iii) Treatment with EPA and DHA
Positive findings have been noted in randomized clinical
trials, where researchers have given either EPA/DHA sup-
plements or a placebo to people currently receiving treat-
ment for unipolar or bipolar depression. When EPA was
added to patients' normal regimen of antidepressants,
EPA made the antidepressants more effective in treating
depression than the placebo [64]. Similarly, in a study of
childhood depression, children who received EPA and
DHA in addition to their medication had significantly
improved depression compared with children who
received their medication and a placebo [65]. EPA also
helped stabilize symptoms of bipolar disorder in a 12-
week double-blind trial [66].International Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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In a recent review, EPA had efficacy in the treatment of
depression in four of the six studies reviewed [67]. The
authors found that 1 gram of EPA per day was the effective
dose. Doses higher than two grams seemed to have the
reverse effect [67]. EPA affects the function of both the
proinflammatory cytokines and the eicosanoids. The
eicosanoids include prostaglandins, leukotrienes and
thromboxanes [57]. Given its direct action on proinflam-
matory cytokines, the efficacy of EPA as a treatment for
depression is consistent with previous studies on depres-
sion and inflammation.
A preliminary study demonstrated that EPA and DHA may
have efficacy in the treatment of postpartum depression.
The study was limited, however, by a small sample, no
control group, and subjects who were not blind to the
treatment condition. This study was intriguing, however,
because depression decreased 48% to 51% in the eight-
week study period [6]. At the very least, these findings sug-
gest that a follow-up study would be useful.
(iv) DHA in the perinatal period
During the perinatal period, DHA appears to be particu-
larly important [68]. Pregnant women's diets are often
deficient in DHA, which is unfortunate given babies' high
need for it in utero. And this may put their mothers at risk
for depression. As Rees and colleagues describe, during
the last trimester of pregnancy, babies accumulate an aver-
age of 67 mg/day of DHA [57]. The average intake for Aus-
tralian mothers is 15 mg/day. In contrast, DHA
consumption among Japanese, Koreans, and Norwegians
is about 1000 mg/day. Because babies need DHA for brain
and vision development, women's bodies will preferen-
tially divert DHA to the baby, and the baby will take the
DHA it needs from maternal stores. With each subsequent
pregnancy, mothers are further depleted [36,57]. Current
recommended intake is 200 to 400 mg/day as a minimum
dose.
DHA appears to have a role in the prevention of depres-
sion, but according to two recent reviews, has no efficacy
in treatment of depression when used alone [67,69]. In
the Adelaide Mothers' and Babies' Iron Trial, a 1%
increase in plasma DHA was related to a 59% decrease in
depressive symptoms postpartum [57]. In a large popula-
tion study, women who consumed high amounts of sea-
food during pregnancy and had high levels of DHA in the
milk had lower rates of postpartum depression [70].
DHA may have another effect that could help prevent
depression postpartum. In a study of infant sleep, moth-
ers with high levels of DHA during pregnancy had babies
who exhibited a more mature sleep pattern in the first few
days of life [71]. The investigators examined the ratio of
quiet to active sleep using a monitor placed beneath the
crib mattress. A higher percentage of quiet sleep is charac-
teristic of older babies, and is considered a more mature
sleep pattern. Babies whose mothers had high levels of
DHA during pregnancy exhibited more mature sleep pat-
terns as neonates. The investigators concluded that babies
of high-DHA mothers had more mature central nervous
systems than babies of mothers who were low in DHA.
Although this was not study of depression per se, babies
with more mature sleep patterns also allow mothers to get
more uninterrupted sleep – and this could have an indi-
rect effect on their mothers' mental health [71].
(v) Sources of EPA and DHA
As the previously cited studies indicate, women are often
deficient in long-chain omega-3 fatty acids during the
perinatal period. However, pregnant or breastfeeding
women often need to limit the amount of fish they eat,
the prime source of EPA and DHA, because of contami-
nants in seafood. Fortunately, there are a alternative
sources of EPA and DHA that are tested for contaminants
and are contaminant free. A listing of sources of EPA/DHA
that are tested for contaminants can be seen in Additional
file 1.
(b) Other anti-inflammatory treatments for depression
In addition to omega-3s, several standard treatments for
depression are also anti-inflammatory. For example, the
herbal antidepressant St. John's wort has long been
known to be anti-inflammatory [72]. Traditional antide-
pressants are also anti-inflammatory and this may explain
their efficacy. For example, a recent study compared C-
reactive protein levels in cardiac patients with major
depression before and after treatment with selective sero-
tonin reuptake inhibitors (SSRIs). In these patients, C-
reactive protein dropped significantly after treatment,
independent of whether depression resolved [73].
One could even argue that cognitive therapy is anti-
inflammatory. Two recent studies have demonstrated that
negative beliefs, such as hostility, can increase the levels of
proinflammatory cytokines – especially IL-6 [74,75]. Cog-
nitive therapy is a treatment for depression with known
efficacy [76]. The primary goal of cognitive therapy is to
reduce negative cognitions. Since negative cognitions
increase inflammation, reducing their occurrence will
have physical effects as well – primarily reducing inflam-
mation.
Conclusion
Recent research has identified inflammation as a key fac-
tor in depression, and inflammatory response system is
triggered by both physical and psychological stress. Post-
partum women are particularly at risk because their
inflammation levels are naturally elevated in the last tri-
mester of pregnancy, and this elevation continues throughInternational Breastfeeding Journal 2007, 2:6 http://www.internationalbreastfeedingjournal.com/content/2/1/6
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the postpartum period. Two approaches may prevent
depression or reduce its severity: lowering maternal stress
and reducing inflammation. Breastfeeding has been
shown to reduce stress and protect maternal mood.
Breastfeeding also reduces stress of babies of depressed
mothers and protects them from the harmful effects of
maternal depression. Treatment approaches that are anti-
inflammatory have efficacy in treating depression. These
include EPA and DHA, exercise, cognitive therapy, herbal
anti-depressants such as St. John's wort, and standard
antidepressants. Research is needed to assess if anti-
inflammatory approaches used proactively can prevent
depression from occurring in the first place.
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